Lead digital health initiatives for clients in health, life sciences, biopharmaceuticals, insurance, and direct-to-patient verticals. This includes strategy, planning, operations, commercialization, business development, partnerships, business and customer insight generation, change management and go-to-market execution.Collaborate closely with IT and external partners to develop and commercialize AmerisourceBergen's proprietary digital solutions (Cameron Stewart LifeScience financial assistance solutions, AvidityHealth platform and Chronically Simple patient / caregiver tool) as well as all our partner solutions.

Cameron Stewart LifeScience was acquired in late 2015 by Innomar Strategies Inc., a part of AmerisourceBergen. CSL is now an affiliate of Innomar Strategies.David’s healthcare industry experience spans over 25 years and includes several senior commercial management positions. David has gained Canadian and global experience in many therapeutic areas, including CNS/Neuroscience, Endocrinology, Cardiovascular, ID, Women’s Health, Pain and Inflammation, Gastroenterology as well as specialty, biologics, SEBs and rare diseases. He has worked for several leading pharmaceutical companies, including Eli Lilly, Roche, Wyeth and for the past 10 years with CSL/Innomar Strategies. David’s strategic insight and innovative approach is helping clients achieve successful implementation of strategies to address product launches, new indications, market access & reimbursement challenges and lifecycle management issues.Innomar Strategies is Canada’s leading service provider for specialty pharmaceuticals. Through their Integrated Service Model, they deliver customized solutions to improve product access, increase supply chain efficiency, and enhance patient care. Innomar is the trusted expert in specialty pharmaceuticals with an unwavering commitment to patients.Cameron Stewart LifeScience Canada Inc. (CSL) provides innovative and strategic programs for healthcare companies. Through their exclusive partnership with ClaimSecure, they implement and manage card based financial assistance and compassionate care programs, early adoption and experience programs, clinical trial applications, trial prescription programs, programs to offset formulary bias and post patent brand enhancement (LOE) programs.

Cameron Stewart LifeScience (CSL) provides innovative and strategic programs for healthcare companies. Through our exclusive partnership with ClaimSecure, we implement card based trial prescription programs, financial assistance and compassionate care programs, early adoption and experience programs, clinical trial applications, programs to offset formulary bias and post patent brand enhancement programs.

P&L responsibilities for CNS portfolio (Effexor XR for depression, generalized anxiety disorder, social phobia and panic disorder) and Women's Health (Alesse - oral contraception, Premarin - hormone replacement therapy), as well as all pipeline products in these therapeutic areas.

Cordarone (amiodarone) tablets and IV for ventricular and atrial fibrillation. Tazocin (tazo-bactam) IV for moderate to serious hopsital and community acquired infections.

Pre-launch and launch strategy and tactics for Verdia (ARB).

Cardiovascular, Stroke, Pain, CNS, Infectious Disease, Emergency Medicine, Dermatology

Sales Rep in Saskatchewan. Manager Special Projects - Head Office - included Product Management - Prozac, CHE, Corporate Affairs, Pricing and Tendering, HR.